What is the difference between Osimertinib and Osimertinib

Osimertinib (Osimertinib) and osimertinib are two different ways of writing the same drug. They are both targeted drugs used to treat non-small cell lung cancer (NSCLC) and are usually effective for patients with EGFR gene mutations. Osimertinib is also used under other names, such as Osimertinib, AZD9291, etc. It is also sold under the trade name Tagrisso.

Osimertinib is a potent, orally effective, third-generation EGFR inhibitor that can inhibit the activation of the EGFR signaling pathway, thereby inhibiting the growth of tumor cells. Therefore, these two writing methods are equivalent, but different doctors or pharmacists may use different expression methods due to different habits or input systems. Mixed responses were detected in 15% of patients with T790M NSCLC. This finding suggests that in a single patient who develops resistance to EGFR-TKIs, several different resistance mechanisms are active. Osimertinib is basically effective in tumors that have acquired resistance to EGFR-TKIs due to the T790M mutation. During the use of osimertinib, patients need to pay close attention to their physical condition and promptly report any symptoms of discomfort to the doctor so that the doctor can adjust the treatment plan in a timely manner.

OsimertinibThe original drug has been launched in China and has been covered by medical insurance. The price of 80mg*30 tablets per box may be around 5,000 yuan, which is relatively expensive. Currently available overseas Osimertinib generics, such as the specifications produced by Bangladesh Pharmaceutical FactoryThe price of each box of 80mg*30 tablets may be more than 800 yuan (the price may fluctuate due to exchange rate effects), which is relatively cheap. Osimertinib generics have basically the same pharmaceutical ingredients as the original drugs sold domestically and abroad. For more drug information and specific prices, please consult Yaode Medical Consultant.